Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.69 | N/A |
| PEG Ratio (TTM) | 0.61 | N/A |
| P/S Ratio (TTM) | 0.43 | N/A |
| P/B Ratio (TTM) | 2.26 | N/A |
| P/FCF Ratio (TTM) | -28.08 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.61 | N/A |
| Price to 5YR AVG FCF Ratio | -3.24 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -167.48% | N/A |
| ROE (TTM) | -690.43% | N/A |
| Net Profit Margin (TTM) | -34.91% | N/A |
| ROIC 5YR AVG | -405.80% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -29.47% | -65.49% | -42.61% |
| Revenue | 143.94% | 3,188.40% | 1,949.35% |
| Net Income | -51.68% | -73.51% | -57.18% |
| Cash Flow | -27.74% | -2,045.96% | -1,240.59% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.91 | N/A |
| Quick Ratio (TTM) | 1.86 | N/A |
| D/E Ratio (TTM) | 0.28 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 15.71% | N/A |